{
    "doi": "https://doi.org/10.1182/blood-2020-134578",
    "article_title": "Native T1 Values and Cardiac Involvement in Patients with Thalassemia Major ",
    "article_date": "November 5, 2020",
    "session_type": "112.Thalassemia and Globin Gene Regulation",
    "abstract_text": "Background. The T2* cardiovascular magnetic resonance (CMR) is the gold standard for the non invasive detection of myocardial iron overload (MIO). The native myocardial T1 mapping has been proposed as a complementary tool, thanks to its higher sensitivity in presence of small amounts of iron, but no data are available in literature about its clinical impact. Objective: To explore the clinical impact of T1 mapping for detecting cardiac complications in thalassemia major (TM). Methods. We considered 146 TM patients (87 females, 38.7\u00b111.1 years) consecutively enrolled in the Extension-Myocardial Iron Overload in Thalassemia Network. Three parallel short-axis slices of the left ventricle (LV) were acquired with the Modified Look-Locker Inversion recovery (MOLLI) sequence. The native T1 values in all 16 myocardial segments were obtained and the global value was the mean. Results. Twenty-one patients had an history of cardiac complications: 11 heart failure, 8 arrhythmias (7 supraventricular and 1 ventricular), and 2 pulmonary hyperthension. Patients with cardiac complications had significantly lower global heart T1 values (879.3\u00b1121.9 ms vs 963.2\u00b198.5 ms; P<0.0001) (Figure) but comparable T2* values (33.32\u00b111.66 ms vs 37.17\u00b19.15 ms; P=0.116). Cardiac complications were more frequent in the group of patients with reduced global heart T1 value (<928 ms for males and <989 ms for females) compared to the group with normal global heart T1 value (71.4% vs 39.5%; P=0.009). Odds ratio (OR) for cardiac complications was 3.8 (95%CI=1.3-10.9) for patients with reduced global heart T1 value versus patients with normal global heart T1 value. Conclusion: We found out a significant association between decreased native global heart T1 values and a history of cardiac complications, suggesting that an early detection of myocardial iron burden by native T1 can support the clinicians in modifing chelation therapy earlier. Figure View large Download slide Figure View large Download slide  Close modal Disclosures Pepe: ApoPharma Inc.: Other: no profit support; Bayer: Other: no profit support; Chiesi Farmaceutici S.p.A.: Other: no profit support and speakers' honoraria. Pistoia: Chiesi Farmaceutici S.p.A.: Other: speakers' honoraria. Meloni: Chiesi Farmaceutici S.p.A.: Other: speakers' honoraria.",
    "author_names": [
        "Alessia Pepe, MD PhD",
        "Nicola Martini",
        "Antonio De Luca",
        "Vincenzo Positano",
        "Laura Pistoia, PhD",
        "Zelia Borsellino",
        "Valentina Carrai, MD",
        "Maria Grazia Sanna",
        "Pier Paolo Bitti",
        "Sara Gentili",
        "Aurelio Maggio, MD",
        "Gianfranco Sinagra",
        "Antonella Meloni, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Alessia Pepe, MD PhD",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Nicola Martini",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio De Luca",
            "author_affiliations": [
                "Cardiovascular Department, University of Trieste, Trieste, Italy "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vincenzo Positano",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Laura Pistoia, PhD",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Zelia Borsellino",
            "author_affiliations": [
                "Unit\u00e0 Operativa Complessa Ematologia con Talassemia, ARNAS Civico \"Benfratelli-Di Cristina\", Palermo, Italy "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Valentina Carrai, MD",
            "author_affiliations": [
                "Ematologia, AOU Careggi, Firenze, Italy "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Grazia Sanna",
            "author_affiliations": [
                "Servizio trasfusionale Aziendale, Azienda Ospedaliero-Universitaria di Sassari, Sassari, Italy "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pier Paolo Bitti",
            "author_affiliations": [
                "Dipartimento dei Servizi, Presidio Ospedaliero \"San Francesco\" ASL Nuoro, Nuoro, Italy "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sara Gentili",
            "author_affiliations": [
                "Unit\u00e0 Operativa Immunoematologia e Medicina Trasfusionale, Ospedale \"San Donato\", Arezzo, Italy "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Aurelio Maggio, MD",
            "author_affiliations": [
                "Ematologia II con Talassemia, Ospedale \"V. Cervello\", Palermo, Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gianfranco Sinagra",
            "author_affiliations": [
                "Cardiovascular Department, University of Trieste, Trieste, Italy "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonella Meloni, PhD",
            "author_affiliations": [
                "MRI Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-20T15:42:09",
    "is_scraped": "1"
}